Minodronic acid
- Generic Name
- Minodronic acid
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C9H12N2O7P2
- CAS Number
- 180064-38-4
- Unique Ingredient Identifier
- 40SGR63TGL
- Indication
Investigated for use/treatment in multiple myeloma, breast cancer, osteoporosis, and lung cancer.
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy and Safety of Minodronate in Patients With Low Back Pain
Phase 4
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-12-09
- Last Posted Date
- 2022-12-09
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 72
- Registration Number
- NCT05645289
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Pharmacokinetics and Tolerability of Minodronic Acid and Food and Age Effects on the Pharmacokinetics
- First Posted Date
- 2014-11-20
- Last Posted Date
- 2014-11-20
- Lead Sponsor
- Wuhan Union Hospital, China
- Target Recruit Count
- 48
- Registration Number
- NCT02295436
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath